Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its integrated drug creation platform comprises AI models aimed at designing better antibody therapeutics, including against hard-to-drug targets, as well as improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Absci Corporation

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbSci (ABSI) and RenovoRx (RNXT) with bullish sentim...

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and RenovoRx (RNXT)

Guggenheim analyst reiterated a Buy rating on AbSci yesterday and set a price target of $10.00. The company’s shares closed yesterday at $3.01. The...

AbSci (ABSI) Gets a Buy from Guggenheim

In a report released today, Gil Blum from Needham maintained a Buy rating on AbSci, with a price target of $7.00. Blum covers the Healthcare sector...

AbSci (ABSI) Gets a Buy from Needham

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fractyl Health, Inc. (GUTS), AbSci (ABSI) and Alnylam Pharma (ALN...

Analysts Conflicted on These Healthcare Names: Fractyl Health, Inc. (GUTS), AbSci (ABSI) and Alnylam Pharma (ALNY)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amylyx Pharmaceuticals Inc (AMLX), AbSci (ABSI) and ...

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), AbSci (ABSI) and Medtronic (MDT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbSci (ABSI) and Cochlear (CHEOF) with bullish senti...

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and Cochlear (OtherCHEOF)

AbSci ( ($ABSI) ) has provided an update. On March 24, 2026, Absci reported fourth quarter and full-year 2025 results, highlighting clinical progre...

Absci Reports 2025 Results and Advances ABS-201 Program

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Healthequity (HQY – Research Report) and AbSci (ABSI...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ABSI	$2.98	+2.05%	2.50M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ABSI	$2.98	+2.1%	2.50M
3
4
5
6

ABSI

ABSI

Get Absci Corporation Data in Excel

Get Absci Corporation Data in Excel